EU regulator starts a review of Russia’s COVID-19 vaccine

International

Russia’s Sputnik V coronavirus vaccine arrives at Kosice Airport, Slovakia, Monday March 1, 2021. Hard-hit Slovakia signed a deal to acquire 2 million dozes of Russia’s Sputnik V coronavirus vaccine. The country’s prime minister says Slovakia will get one million shots in next two months while another million will arrive in May and June. (Frantisek Ivan/TASR via AP)

MOSCOW (AP) – The European Medicines Agency said it has started a rolling review of Sputnik V, many months after the vaccine was first approved for use in Russia and after dozens of countries around the world have authorized it.

Despite skepticism about Russia’s hasty introduction of the vaccine, which was rolled out before it had completed late-stage trials, the vaccine appears to be safe and effective.

According to a study published in the journal Lancet, Sputnik V was about 91% effective in preventing people from becoming severely ill with COVID-19.

Copyright 2021 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.